UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2020
Commission File Number: 001-13742
ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)
Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7):
ISRAEL CHEMICALS LTD.
INCORPORATION BY REFERENCE
This report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration Number:
333-205518) of Israel Chemicals Ltd. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. In addition, this report on Form 6-K shall be deemed to
be incorporated by reference into the Israeli Shelf Prospectus of Israel Chemicals Ltd. filed with the Israel Securities Authority and dated March 4, 2019 (Filing Number: 2019-02-018507) and to be a part thereof from the date on which this report is
filed, to the extent not superseded by documents or reports subsequently filed or furnished.
ISRAEL CHEMICALS LTD.
| |
1.
|
Results of the Annual General Meeting of Shareholders
|
Item 1
Results of the Annual General Meeting of Shareholders
Further to the notice of the Annual General Meeting of shareholders on Form 6-K dated March 9, 2020 (Accession no 0000950103-20-004934), the Company hereby reports that all items on the agenda of the Annual General Meeting that was held today, April 23, 2020, which are listed below, were approved:
|
1. |
Election of Yoav Doppelt, Aviad Kaufman, Avisar Paz, Sagi Kabla, Ovadia Eli, Reem Aminoach, Lior Reitblatt and Tzipi Ozer Armon to serve as directors, effective as
of the date of the Meeting.
|
|
2. |
Reappointment of Somekh Chaikin, a member of KPMG International, as our independent auditor.
|
|
3. |
Approval of equity compensation for 2020 for certain directors.
|
|
4. |
Approval of an amendment to the Company’s Memorandum of Association and Articles of Association, to facilitate a change in the Company's formal name to "ICL" or to
a similar name.
|
In addition, the Company's audited financial statements for the year ended December 31, 2019 were reviewed.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
| |
Israel Chemicals Ltd.
|
|
| |
|
|
|
|
|
By:
|
/s/ Kobi Altman |
|
| |
|
Name: Kobi Altman |
|
| |
|
Title: Chief Financial Officer |
|
| |
Israel Chemicals Ltd.
|
|
| |
|
|
|
|
|
By:
|
/s/ Aya Landman |
|
| |
|
Name: Aya Landman |
|
| |
|
Title: Global Company Secretary |
|
| |
|
|
|
Date: April 23, 2020